The myPath Melanoma Test utilizes the expression of 14 signature genes, including PRAME, CXCL9, CXCL10, S100A7, S100A8, and S100A9, and nine reference genes to distinguish BN from CMM [55,56,57]. The gene discussed is S100A9; the disease is melanoma.